BONE BIOLOGICS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 3.03 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-03-02
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 0.00 shares.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-12-31 was -2.58M shares.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-09-30 was 1.61M shares.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 3.03M shares, a 486.74% increase from fiscal 2024.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 516.63K shares, a 242.30% increase from fiscal 2023.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 150.93K shares, a 174.60% increase from fiscal 2022.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 54.96K shares, a 96.99% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-02 | 3.03M shares 10-K · filed 2026-03-02 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 3.03M shares 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 3.03M shares 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | -2.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -973.75K shares derived: sum of 2 quarters · filed 2026-03-02 | -973.75K shares derived: sum of 3 quarters · filed 2026-03-02 | 516.63K shares 10-K · filed 2026-03-02 | 3.10M shares 10-K · filed 2025-02-26 |
| 2024-09-30 | 1.61M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 1.61M shares derived: sum of 2 quarters · filed 2024-11-14 | 3.10M shares 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 1.49M shares 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 1.49M shares 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | 150.93K shares 10-K · filed 2025-02-26 | ||||
| 2022-12-31 | 54.96K shares 10-K · filed 2024-02-21 | 13.19M shares 10-K · filed 2023-03-30 | |||
| 2021-12-31 | 1.83M shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |